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of three individuals with type 2 diabetes do not exercise
regularly (Thomas et al., 2004), and very few meet cur-
Abstract
Exercise is considered a cornerstone in the prevention and
treatment of type 2 diabetes, but few individuals with type 2
diabetes exercise according to guidelines. We investigated the
effect of two time efficient high intensity exercise interventions
on exercise capacity, glycemic control and other cardiometabol-
ic risk factors in patients with type 2 diabetes. Twenty-one
individuals with type 2 diabetes were randomly assigned to low
volume high intensity interval exercise (HIIE; 27 minutes/bout;
10x1-minute at 90 % of HRmax; n = 10) or extremely low vol-
ume sprint interval exercise (SIE; 10 minutes/bout; 2x20  se-
conds at maximum achievable intensity; n = 11) 3 days/week for
12 weeks. Aerobic exercise capacity (VO2peak), glycosylated
hemoglobin (HbA1c), blood pressure and body composition were
measured at baseline and post test. Both HIIE and SIE improved
VO2peak (3.3 mL∙min-1∙kg-1, 10.4 %), p < 0.01, and 1.4 mL∙min-
1∙kg-1 (4.6 %), p = 0.03, respectively). Only HIIE reduced body
fat percentage (4.5 %, p = 0.04) and two minute heart rate re-
covery (11.0 bpm, p = 0.02). Neither HIIE nor SIE improved
HbA1c. In conclusion, this study  indicates that substantially
lower exercise volumes than recommended in current guidelines
can improve aerobic exercise capacity in individuals with type 2
diabetes. However, 12 weeks of time efficient high intensity
exercise did not improve glycemic control, and interventions of
longer duration should be investigated.
Key words: Low volume exercise, VO2peak, HbA1c, type 2
diabetes, cardiovascular risk.
Introduction
Type 2 diabetes is characterized by reduced aerobic exer-
cise capacity (Wei et al., 1999) and poor glycemic control
(Unwin et al., 2010). Both reduced aerobic exercise ca-
pacity and elevated glycosylated hemoglobin (HbA1c) are
associated with increased cardiovascular risk in type 2
diabetes (Emerging Risk Factors Collaboration et al.,
2010; Wei et al., 2000; Zhang et al., 2012). Compared
with healthy individuals, type 2 diabetics have a 2–4
times increased risk of developing cardiovascular disease
(Emerging Risk Factors Collaboration et al., 2010), and
more than 70 % of this patient population die of cardio-
vascular causes (Laakso, 2001).
Exercise training can improve aerobic exercise ca-
pacity (VO2peak) (Boule et al., 2003) and glycemic control
(Boule et al. 2001) in type 2 diabetes. The benefits of
exercise training on overall mortality and cardiovascular
risk exceed those explained by glucose lowering alone
(Wei et al., 2000, Church et al., 2005). However, two out
rent exercise recommendations (Colberg  et al., 2010).
Lack of time is reported as one of the main reasons for the
inactivity (Korkiakangas et al., 2009). This calls upon
alternative exercise strategies that are less time consum-
ing, yet effective to improve VO2peak, glycemic control
and other cardiometabolic risk factors.
In type 2 diabetes, high intensity interval exercise
seems to be superior to continuous moderate exercise in
improving aerobic exercise capacity and reducing several
cardiovascular risk factors (Backx et al., 2011; Hollekim-
Strand et al., 2014; Mitranun et al., 2014). Recent re-
search indicates that low- and even extremely low volume
intermittent high intensity exercise can be  effective in
improving glycemic control in type 2 diabetes (Little et
al., 2011) as well as insulin sensitivity and VO2peak in
sedentary, healthy men (Metcalfe et al., 2012).
Thus, the aim of this pilot study was to investigate
the effects of low volume high intensity interval exercise
(HIIE; 10x1-minute intervals at 90 % of maximum heart
rate (HRmax)) and extremely low volume sprint interval
exercise (SIE; 2x20-seconds intervals at maximum
achievable intensity) on aerobic exercise capacity
(VO2peak), glycemic control (HbA1c), insulin resistance
(HOMA-IR), blood pressure and body composition in
individuals with type 2 diabetes. The main hypothesis was
that in type 2 diabetes individuals, time effective exercise
of HIIE and SIE is effective in improving cardiometabolic
risk factors, but HIIE more than SIE.
Methods
Study participants
In this 12 week randomized exercise trial, individuals
with type 2 diabetes were recruited through a local news-
paper and advertising at the St. Olavs Hospital, Trond-
heim University Hospital, Norway. The study was con-
ducted between August 2013 and January 2014.
Inclusion criteria were age 20–65 years, diagnosed
with type 2 diabetes within the past 10 years with no use
of insulin. Exclusion criteria were known cardiovascular
disease or lung disease, untreated hypertension of ≥
140/90 mmHg, orthopedic or neurological restrictions,
severe obesity (BMI ≥ 35), pregnancy, inability to exer-
cise, drug or alcohol abuse, and reluctance to sign the
consent form. Subjects were not eligible if they were
more physically active than recommended in current
exercise guidelines, e.g. more than 150 min/week of exer-
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cise at moderate intensity or greater (Colberg et al., 2010),
assessed by a self-reported activity diary.
A total of 21 subjects were included. The unit of
Applied Clinical Research at the Norwegian University of
Science and Technology performed the randomization
procedure. The protocol was approved by the Regional
Committee for Medical and Health Research Ethics of
Central Norway  and was registered with the Clinical
Trials Registry (ClinicalTrials.gov identifier:
NCT02340260). Informed consent was obtained from all
participants and all participants were insured.
Outcome measures
The primary outcome measure was glycosylated hemo-
globin (HbA1c). Secondary outcome measures were aero-
bic exercise capacity, measured as peak oxygen uptake
(VO2peak), blood glucose, insulin resistance (HOMA-IR),
blood pressure and body composition.
Exercise training protocols
The HIIE protocol was described in detail previously
(Little et al., 2011). Participants performed  3 minutes
warm up at 70 % of HRmax (determined from the exercise
capacity test, methodology described later), 10x1-minute
intervals of fast uphill walking or running at approximate-
ly 90 % of HRmax with 75 seconds of active recovery
between each interval, and 3 minutes cool down. Heart
rate was continuously monitored by an experienced exer-
cise physiologist throughout the intervention period, and
treadmill speed and/or inclination was successively ad-
justed throughout the exercise intervention to make sure
heart rate levels were met.
The SIE protocol was adapted to treadmill from a
protocol previously described for stationary bicycle
(Metcalfe et al., 2012). Participants performed 3 minutes
warm up at 70 % of HRmax, 2x20-seconds sprint intervals
at maximum achievable intensity, with approximately 3
minutes active recovery between intervals at an intensity
of 70 % of HRmax, and subsequently 3 minutes cool down.
The treadmill was set to 20 % incline and the first one or
two sessions were used to find maximum achievable
running speed. Speed was successively adjusted to ensure
the intensity was according to the protocol throughout the
intervention period.
Both groups exercised 3 times a week throughout
the 12 week intervention. Exercise times per session in
the HIIE and SIE group were 27 minutes and 10 minutes,
respectively. It was not the aim of this trial to compare
two isocaloric exercise protocols, but rather two protocols
with different potential to reduce the time-burden associ-
ated with exercise in type 2 diabetes. Thus, the exercise
protocols were not matched for energy expenditure.
Clinical and laboratory examinations
All measurements were performed at baseline and after
completion of the 12 weeks of exercise. Post test meas-
urements were made between 48 and 72 hours after the
last exercise bout, in order to reduce the acute effects of
the final exercise session.
Peak oxygen uptake
Exercise capacity (VO2peak) was measured during walking
on a treadmill (Woodway PPS 5, Woodway, Weil am
Rheim, Germany) by indirect calorimetry as previously
described (Rognmo et al. 2004) using MasterScreen Spi-
rometer (Jaeger Oxycon Pro, Jaeger GmbH & Co KG,
Würzburg, Germany). However, due to unexpected tech-
nical problems with the Jaeger device during the final
days of pre-testing, VO2peak in some of the patients (n = 4
[HIIE; n = 2, SIE; n = 2]) were measured using Metamax
II (Cortex, Leipzig, Germany). These patients (n  = 4)
were also tested with Metamax II after completion of the
exercise intervention, in order to prevent the measuring
method to inflict on the results.   A subjective rating of
perceived exertion (RPE; the Borg Scale) from 6 (“no
feeling of exertion”) to 20 (“very, very hard”) was ob-
tained immediately following the test.
During the test, heart rate was continuously rec-
orded using Polar RS 400 monitors (Polar Electro,
Kempele, Finland) to obtain maximum attainable heart
rate. HRmax was determined by adding five beats to peak
heart rate obtained during the test, as few subjects reach
their true HRmax during a test of VO2peak (Ingjer 1991).
This calculation of HRmax is also routinely used in our
research group to make sure that the HR obtained during
exercise sessions is not lower than intended. Heart rate
recovery was calculated as the difference between peak
heart rate  and heart rate one minute and two minutes
following exhaustion, with the subjects standing still on
the treadmill between measurements.
Biochemical measurements
Blood samples were collected in the fasted state (≥ 10
hours). HbA1c was analyzed from EDTA tubes using an
automated immunological method (Cobas Integra 400,
Roche Diagnostics, Mannheim, Germany), serum blood
glucose was analyzed using an enzymathic method (Mod-
ular P., Roche Diagnostics, Mannheim, Germany), and
insulin c-peptide was analyzed by immonulogical methol-
ogy (DPC Immulite 2000, Siemens, Erlangen, Germany),
using standard procedures at St. Olavs Hospital, Trond-
heim University hospital. Overall insulin resistance was
calculated using the homeostasis assessment model
(HOMA-IR).
Resting heart rate and blood pressure
Blood pressure was measured in sitting position using a
Criticare Comfort Cuff 506N (Criticare Systems Inc.,
Wisconsin, USA). After 5 minutes rest, the mean systolic
and diastolic blood pressure of three subsequent meas-
urements was noted and used in later analysis.
Body composition
Waist circumference was measured in expiration, midway
between the lower lateral costal margin and the iliac crest,
with the subject standing. The average value of three
subsequent measurements  was collected for analysis.
Body weight, BMI, muscle mass and fat percentage were
recorded using bioimpedance (InBody 720, Biospace CO,
Ltd, Seoul, Korea) in the fasted state (≥ 10 hours).
Statistical methods
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Normal distribution of the data was verified by a Kolmo-
gorov-Smirnov test. The student t-tests were used to ana-
lyze between group differences at baseline and within
group mean absolute changes in physiological, anthropo-
metrical and biochemical variables during the 12-weeks
intervention period. A p-value of 0.05 was considered
statistically significant. Because of significant between
group differences at baseline in the main outcome varia-
ble, ANCOVA with baseline HbA1c as a covariate was
used to analyze between group changes from baseline to
post test. Results are given as mean ± standard deviation
(SD) in text and tables, and as mean (SEM) in figures
unless stated otherwise. All data analysis was carried out
using SPSS version 21.0 (SPSS Inc, Chicago, Illinois,
USA).
Results
Baseline characteristics and compliance
Participants in the SIE group had higher HbA1c levels at
baseline compared to the HIIE group (p = 0.02; Table 1).
No significant differences at baseline were seen for other
demographic or clinical characteristics (Table 1).
A total of 18 subjects (SIE, n = 9; HIIE, n = 9)
completed the exercise intervention as scheduled. Three
subjects (SIE, n = 2; HIIE, n = 1) dropped out during the
intervention period. One subject in each group dropped
out due to exercise related calf pain, whereas one subject
in the SIE group dropped out without reporting any rea-
son. The HIIE and SIE group performed 96.0 % and 95.4
% of the scheduled exercise sessions at target heart rate,
respectively.
Most of the participants (n = 15) used oral antihy-
perglycemic medication, and the remaining participants (n
= 3) were treated with diet only (Table 1). All participants
complied with their medical treatment regimen and did
not change the medication during the 12 week interven-
tion period.
Peak oxygen uptake
Mean improvements in relative VO2peak were 3.3
mL∙min-1∙kg-1 (10.4 %, p < 0.01) and 1.4 mL∙min-1∙kg-1
(4.3 %, p = 0.03) following HIIE and SIE, respectively
(Table 2; Figure 1). The between group difference of the
improvements were tending towards being significant (p
= 0.052). Only HIIE improved heart rate recovery two
minutes after the exercise test to exhaustion (11.0 bpm, p
= 0.02), and the improvements were almost significantly
different from SIE (p = 0.052; Table 2).
Table 1. Baseline characteristics. Data represents mean and
(standard deviation) unless otherwise noted.
HIIE (n=9) SIE (n=9)
Age (years) 56.5 (6.5) 49.6 (10.6)
Female/male (n) 4/5 4/5
Diabetes duration (years) 4.2 (2.1) 5.3 (2.5)
HbA1c (%) 6.53 (.96) 7.87 (1.21)*
BMI (kg∙m-2) 26.3 (3.0) 29.5 (3.9)
Fat percentage 28.8 (6.7) 31.4 (6.2)
Systolic blood pressure (mmHg) 129.3 (16.3) 135.3 (11.0)
Diastolic blood pressure (mmHg) 76.8 (7.2) 84.44 (12.0)
Glucose-lowering medication (n) 7 8
Antihypertensive medication (n) 2 4
* p < 0.05 between-group difference. HbA1c = glycosylated
hemoglobin, BMI = body mass index.
Biochemical measurements, blood pressure and body
composition
Neither HbA1c, fasting blood glucose nor HOMA-IR
changed in either group following the exercise interven-
tion (Table 2). There were strong negative correlations
between baseline HbA1c (%) and changes in HbA1c after
12 weeks, reaching statistical significance in the SIE
group only (HIIE; r = -0.66, p = 0.052, SIE; r = -0.88, p <
0.01).
SIE decreased diastolic blood pressure by 5.7
mmHg (p = 0.04; Table 2). However, this was not signifi-
cantly different from HIIE (p = 0.59). Only HIIE reduced
body fat percentage by 4.5 % (p = 0.04). The change was
not significantly different from SIE (p = 0.07). There was
no change in BMI, waist circumference or skeletal muscle
mass in either group.
Table 2. Changes in cardiometabolic risk factors. Data represents mean and (standard deviation).
Baseline
HIIE (n=9)
12 weeks Change Baseline
SIE (n=9)
12 weeks Change
HIIE vs. SIE
p interaction†
VO2peak (mL∙min-1∙kg-1) 31.5 (5.8) 34.8 (5.3) 3.3 (2.2)** 32.0 (9.5) 33.4 (8.9) 1.4 (1.6)* .052
VO2peak (L∙min-1) 2.41 (.75) 2.64 (.76) .23 (.2)** 2.98 (1.30) 3.11 (1.33) .13 (.16)* .30
2-minute HRR (bpm) 46.6 (13.1) 57.6 (11.1) 11.0 (11.1)** 52.9 (12.9) 53.6 (14.3) .7 (5.7) .052
HbA1c (%) 6.53 (0.96) 6.47 (0.75) -.06 (.42) 7.87 (1.21) 7.57 (0.80) -.30 (.58) .23
HbA1c (mmol∙mol-1) 48.0 (10.6) 47.2 (8.2) -.8 (4.6) 62.4 (13.4) 59.2 (8.8) -3.2 (6.6) .20
HOMA-IR 2.04 (.45) 1.81 (.41) -.23 (.35) 2.42 (.79) 2.34 (0.66) -.08 (.84) .14
GlucoseFast (mmol∙mol-1) 7.83 (1.66) 7.35 (1.57) -.48 (.70) 9.39 (2.65) 8.41 (1.08) -.98 (1.94) .47
Weight (kg) 75.5 (15.9) 74.9 (15.7) -.6 (1.5) 91.4 (20.3) 91.5 (21.3) .1 (2.2) .40
BMI (kg∙m-2) 26.3 (3.0) 26.1 (3.1) -.2 (.5) 29.5 (3.9) 29.5 (3.9) .0 (.7) .51
Fat percentage 28.8 (6.7) 27.5 (6.9) -1.3 (1.6)* 31.4 (6.2) 31.5 (5.4) .04 (1.6) .07
WaistCircum (cm) 93.8 (8.2) 92.5 (7.8) -1.3 (2.0) 103.3 (10.6) 104.2 (11.7) .9 (2.3) .11
SMS (kg) 30.0 (7.7) 30.3 (7.6) .3 (.7) 35.2 (9.4) 35.1 (9.4) -.1 (.8) .32
SBP (mmHg) 129.3 (16.3) 126.3 (14.6) -3.0 (5.5) 135.3 (11.0) 130.7 (10.6) -4.6 (10.7) .99
DBP (mmHg) 76.8 (7.2) 75.9 (8.9) -.9 (5.3) 85.4 (12.0) 79.7 (7.7) -5.7 (7.3)* .59
VO2peak = peak oxygen uptake; HRR = heart rate recovery; HbA1c = glycosylated hemoglobin; HOMA-IR = homeostatic model assessment of insulin
resistance; GlucoseFast = Fasting glucose; BMI = Body mass index; WaistCircum = Waist circumference; SMS = Skeletal muscle mass; SBP = Systolic
blood pressure; DBP = Diastolic blood pressure.
* p < 0.05 and ** p < 0.01 within-group difference. † p value: difference in mean change between groups
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Figure 1. Changes in VO2peak. Data represents mean change in relative VO2peak from baseline to post test. HIIE = high intensity
interval exercise; SIE = sprint interval exercise; VO2peak = peak oxygen uptake.
Discussion
This pilot study shows improved aerobic exercise capaci-
ty in individuals with type 2 diabetes following exercise
durations of 81 and 30 minutes/week, respectively. The
high intensity, time efficient exercise performed in this
study could be implemented to reduce the time barrier
associated with exercise in these individuals. However,
the small amount of weekly exercise was not enough to
yield improvements in glycemic control, which might
have been achieved by a longer duration of the interven-
tion. The strong negative correlations between baseline
values of HbA1c and changes in HbA1c after 12 weeks
could possibly indicate a more positive effect of the exer-
cise intervention in patients with higher HbA1c. However,
this might also be a consequence of the regression to the
mean phenomenon, and requires further investigation in
future trials.
Mean VO2peak at baseline in our study was lower
than age-matched reference values from a general popula-
tion (Aspenes et al., 2011). Subjects with type 2 diabetes
frequently have lower aerobic capacity than healthy sub-
jects of similar age and body mass, and aerobic exercise
capacity in these individuals is primarily determined by
exercise habits (Wei et al., 1999). Our results add to the
growing body of evidence that high intensity interval
exercise is effective in improving exercise capacity in
individuals with type 2 diabetes, and is the first to show
that sprint interval exercise improves VO2peak in this pa-
tient group.
The 3.3 mL∙min-1∙kg-1 improvements in VO2peak af-
ter HIIE in the present study are in line with the findings
in the metaanalysis of Boulé et al. (2003). The results also
support Mitranun et al. (2014), who found that high inten-
sity intermittent exercise improved exercise capacity in
type 2 diabetes patients even if total exercise time was
reduced to half of the recommendations. Improving
VO2peak could be crucial, as  low aerobic capacity is  a
powerful and independent predictor of long-term cardiac
mortality in type 2 diabetes (Church et al., 2005; Wei et
al., 2000). Furthermore, every 3.5 mL∙min-1∙kg-1 increase
in aerobic exercise capacity confers a 12% improvement
in survival in men referred for exercise testing (Myers et
al., 2002).
Our study is the first to show improved VO2peak
following SIE in type 2 diabetes individuals, although the
improvements were smaller than previously seen follow-
ing SIE in healthy subjects (Metcalfe et al., 2012). The
clear trend towards greater improvements following HIIE
than SIE in our study may be due to the difference in
influence of stroke volume during  exercise between
groups (Zhou et al., 2001) and thus cardiac adaptation to
exercise. This is also indicated by the improvement in
heart rate recovery in the HIIE group compared to the SIE
group. Decreased heart rate recovery is associated with
increased risk of cardiovascular disease and all-cause
death among patients with type 2 diabetes, and a higher
fitness level derived from exercise training may positively
affect autonomic function and heart rate recovery in pa-
tients with diabetes (Cheng et al., 2003).
The current study indicates that substantially low-
ering exercise volume from today’s recommendations
hampers the beneficial effects on HbA1c. In contrast,
Mitranun et al. (2013) recently found improved HbA1c
following a weekly 90–120 minutes of high intensity
interval exercise for 12 weeks in type 2 diabetes patients.
The discrepancy between results can possibly be related
to the comparably higher baseline HbA1c-values reported
in the Mitranun et al.’s study (2014). This notion is sup-
ported by informal subgroup observations from our study,
indicating reduced HbA1c following exercise in individu-
als with baseline values above 7 % (data not shown). A
treatment target HbA1c value of 7 % is regarded as cardi-
ovascular disease prevention in type 2 diabetes (American
Diabetes Association, 2014). The potential of low volume
high intensity exercise to improve HbA1c in subjects with
poor glycemic control should be investigated in future
studies. Furthermore, we cannot rule out that an exercise
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period of 12 weeks is too short to change the metabolism
and reduce HbA1c in a group of type 2 diabetes patients
with relatively well-controlled hyperglycemia.
More than 50 % of patients with type 2 diabetes
are obese (Daousi et al., 2006). The HIIE group signifi-
cantly reduced body fat percentage, which is in line with
earlier studies on type 2 diabetes and high intensity inter-
val exercise (Mitranun et al., 2014; Hollekim-Strand et al.
2014; Terada et al., 2013). There was also a trend to re-
duced waist circumference in the HIIE group following
exercise. Fat percentage and waist circumference are
probably better indicators for the effectiveness of the
intervention than changes in BMI, which did not change
in either group after 12 weeks of exercise, indicating that
the total energy expenditure of the interventions was too
small to induce changes in body weight (Ballor and
Keesey, 1991). High intensity intermittent endurance
exercise can increase skeletal muscle mass in overweight
patients with type 2 diabetes, which can explain a reduc-
tion in fat percentage and abdominal fat despite no change
in body weight (Boudou et al., 2003). Although the in-
creased amount of muscle mass following HIIE in this
study was not significant, it seems likely that HIIE initiat-
ed favorable overall changes in body composition. SIE,
however, was not effective in improving body composi-
tion.
Strengths and limitations
The strengths of the present study include the well-
defined exercise interventions and closely supervised
exercise sessions. A main limitation is the small sample
size. There were several trends of improvement, especial-
ly in the HIIE group, and it is possible that these results
would have reached significance if the group size had
been larger. The study also lacks a sedentary control
group, preventing firm conclusions about the pre-post
effect of the exercise interventions.
All subjects were asked to fill out a habitual activi-
ty diary throughout the study, but adherence was low and
the incomplete information was not suited for statistical
analysis. Also, we have no information on dietary habits.
These variables could possibly differ between the two
intervention groups and confound our results. However,
before the study all participants reported to be less physi-
cally active than 150 minutes/week, and were instructed
not to change their activity or diet during the study period.
A lack of a dynamic measure of insulin resistance
(e.g. glycemic clamp or oral glucose tolerance test) is
another limitation. The study is also limited by the use of
clinic blood pressure measurements, as 24-hour record-
ings of ambulatory blood pressure currently are consid-
ered the gold standard. The accuracy of bioimpedance in
measurements of body composition can  also be ques-
tioned. However, the validity of the Inbody720 has been
documented in several studies (Ling et al., 2011). The
present study is the first study to investigate SIE on a
treadmill, which makes the all-out nature of the sprint
intervals slightly different than in previous studies per-
formed on a stationary bicycle.
Conclusion
In conclusion, this pilot study indicates that substantially
lower exercise volumes than recommended in current
guidelines can improve aerobic exercise capacity  and
heart rate recovery in individuals with type 2 diabetes.
However, 12 weeks of time efficient high intensity exer-
cise did not improve glycemic control, and interventions
of longer duration should be investigated.
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Key points
• Low volume high-intensity interval  exercise can
improve peak oxygen uptake in previously seden-
tary individuals with type 2 diabetes
• The weekly exercise volumes in the two interven-
tion groups of 81 and 30 minutes, respectively, is
substantially lower than recommended in current
exercise guidelines and could reduce the time-
barrier associated with exercise among patients
with type 2 diabetes.
• However, 12 weeks of structured, supervised low-
volume exercise did not improve glycemic control,
indicating a need for exercise volumes or longer in-
tervention period.
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